Pardes Biosciences Inc. (PRDS)
NASDAQ: PRDS
· Real-Time Price · USD
2.18
0.02 (0.93%)
At close: Aug 30, 2023, 9:59 PM
Pardes Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -10.78M | -21.45M | -26.16M | -26.21M | -28.23M | -21.43M | -14.31M | -1.22M | -8.14M | -4.53M |
Interest Income | 1.84M | n/a | n/a | 959K | n/a | n/a | n/a | 3K | n/a | n/a |
Pretax Income | -10.78M | -17.8M | -24.22M | -23.34M | -27.64M | -21.44M | -14.35M | -11.51M | -8.14M | -4.52M |
Net Income | -10.78M | -14.17M | -24.22M | -21.42M | -27.34M | -21.44M | -14.35M | -11.51M | -8.14M | -4.52M |
Selling & General & Admin | 5.69M | 6.83M | 6.73M | 6.92M | 7.59M | 8.23M | 3.95M | 1.14M | 1.87M | 1.08M |
Research & Development | 6.93M | 12.98M | 19.43M | 17.38M | 20.34M | 13.2M | 10.36M | 8.08M | 6.27M | 3.44M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -15K | n/a | n/a | 4K | 3K |
Operating Expenses | 12.62M | 19.81M | 26.16M | 24.29M | 27.93M | 21.43M | 14.31M | 11.52M | 8.14M | 4.53M |
Interest Expense | n/a | n/a | n/a | 959K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.62M | 19.81M | 26.16M | 24.29M | 27.93M | 21.43M | 14.31M | 11.52M | 8.14M | 4.53M |
Income Tax Expense | n/a | -3.63M | 25.7M | -1.92M | -298K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 60.21M | 59.77M | 59.34M | 58.38M | 57.69M | 57.04M | 56.77M | 56.65M | 56.65M | 56.65M |
Shares Outstanding (Diluted) | 60.21M | 59.77M | 59.34M | 58.38M | 57.69M | 57.04M | 56.77M | 56.65M | 56.65M | 56.65M |
EPS (Basic) | -0.18 | -0.24 | -0.41 | -0.37 | -0.47 | -0.38 | -0.25 | -0.2 | -0.14 | -0.08 |
EPS (Diluted) | -0.18 | -0.24 | -0.41 | -0.37 | -0.47 | -0.38 | -0.25 | -0.2 | -0.14 | -0.08 |
EBITDA | -12.62M | -19.81M | -23.62M | -24.29M | -27.93M | -21.43M | -14.31M | -1.22M | -2.17M | -4.53M |
EBIT | -10.78M | -17.82M | -22M | -22.38M | -27.93M | -21.43M | -14.31M | n/a | n/a | n/a |
Depreciation & Amortization | -1.84M | 1.65M | -1.9M | 1.92M | 298K | 60.46K | 71.39K | 54K | n/a | n/a |